Brigatinib (BRG) vs Crizotinib (CRZ) in Patients (Pts) With ALK Inhibitor-Naive Advanced ALK plus NSCLC from ALTA-1L

Yang, JCH; Kim, HR; Ahn, MJ; Han, JY; Hochmair, MJ; Lee, KH; Delmonte, A; Campelo, MRG; Kim, DW; Felip, E; Califano, R; Spira, A; Gettinger, S; Tiseo, M; Haney, J; Kerstein, D; Popat, S; Camidge, DR

ANNALS OF ONCOLOGY, 2019; 30 ():